Osteoporosis Health Center
Vitamin C: Good for Your Bones
Sept. 19, 2008 -- A high intake of vitamin C may help reduce bone loss, at least in elderly men, according to a new study.
"Vitamin C had an effect on the [bone density of] hips in men, but it didn't have an effect on women," says Katherine L. Tucker, PhD, a senior scientist at the Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University and senior author of the study. It is published in the Journal of Nutrition.
Vitamin C and Bones: Background
For years, researchers have known that vitamin C is needed for normal bone development and for the formation of collagen, the fibrous protein part of bone, cartilage, and other structures.
But few studies have looked at the relationship between vitamin C intake from food and supplements and bone density, Tucker says.
Vitamin C is an antioxidant vitamin and reduces oxidative stress, which has a negative effect on all cells in the body, she says. "Antioxidants are needed to protect against oxidative stress, therefore protecting against inflammation. Inflammation drives bone resorption, which is basically taking calcium away from the bones. Vitamin C, theoretically, should help slow that resorption."
Vitamin C and Bones: Study Detail
Tucker and her colleagues evaluated the bone density of 213 men and 393 women, average age 75 at the start, over a four-year period to see what association their vitamin C intake had with their bones.
The participants were part of the long-running Framingham Osteoporosis study. The researchers looked at a diet questionnaire given to participants in 1988 or 1989 and again four years later. They evaluated the change in bone density in the hips, spine, and arm over the follow-up. Besides looking at their vitamin C and vitamin E intake, they took into account whether participants smoked and whether the women were on hormone replacement therapy.
Vitamin C and Bones: Study Results
Men with the highest vitamin C intake had the least bone loss in the hip. A similar finding in women was not significant, Tucker says.
The effect became most significant, she says, at the highest level, about 314 milligrams of vitamin C daily from supplements and food. The recommended intake is 75 milligrams daily for women and 90 milligrams daily for men.
"At one hip site [of two measured], for example, men in the highest intake group, who took in 314 milligrams of vitamin C a day in food and supplements but had low calcium intake, did not lose bone density on average," she says, ''whereas those in the lowest group, who took in 106 milligrams, lost 5.6% of their bone."
"The only significant effects on bone loss were found in men who were low in vitamin E or calcium," she says.
Why no effect was not seen in women is complicated, Tucker says. The effects of vitamin C may interact with estrogen use, calcium, and vitamin E, she notes.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.

